Viewing StudyNCT06411379



Ignite Creation Date: 2024-05-19 @ 5:33 PM
Last Modification Date: 2024-10-26 @ 3:29 PM
Study NCT ID: NCT06411379
Status: RECRUITING
Last Update Posted: 2024-05-31
First Post: 2024-05-08

Brief Title: Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
Sponsor: MoonLake Immunotherapeutics AG
Organization: MoonLake Immunotherapeutics AG

Conditions & Keywords Data

Conditions:
Name
Hidradenitis Suppurativa
Keywords:
Name View
Hidradenitis Suppurativa View
Hidradenitis View
Sweat Gland Diseases View
Skin Diseases View
Skin Diseases Bacterial View
Suppuration View
Anti-Inflammatory Agents View
Sonelokimab View
Nanobody View
Apocrine Gland Disease View